204 related articles for article (PubMed ID: 19115673)
21. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone.
Stroet A; Gold R; Chan A
Neurology; 2012 Mar; 78(12):933; author reply 933-4. PubMed ID: 22431743
[No Abstract] [Full Text] [Related]
22. [Acute heart failure in a patient treated by mitoxantrone for multiple sclerosis].
Feuillet L; Guedj E; Eusebio A; Malikova I; Pelletier J; Mundler O; Ali Chérif A;
Rev Neurol (Paris); 2003 Dec; 159(12):1169-72. PubMed ID: 14978418
[TBL] [Abstract][Full Text] [Related]
23. Acute myeloid leukaemia induced by mitoxantrone: case report.
Arruda WO; Montú MB; de Oliveira Mde S; Ramina R
Arq Neuropsiquiatr; 2005 Jun; 63(2A):327-9. PubMed ID: 16100984
[TBL] [Abstract][Full Text] [Related]
24. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
[No Abstract] [Full Text] [Related]
25. A case of acute promyelocytic leukemia presenting with a nonleukemic granulocytic sarcoma of the ovary, with subsequent development of acute myeloid leukemia associated with t(8;21).
Wang X; Liu H; Wu Z; Xu X; Chen X; Zhai Z; Sun Z
Leuk Res; 2009 Apr; 33(4):580-2. PubMed ID: 18804280
[No Abstract] [Full Text] [Related]
26. Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS.
Brassat D; Recher C; Waubant E; Le Page E; Rigal-Huguet F; Laurent G; Edan G; Clanet M
Neurology; 2002 Sep; 59(6):954-5. PubMed ID: 12297591
[TBL] [Abstract][Full Text] [Related]
27. Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?
Taube F; Stölzel F; Thiede C; Ehninger G; Laniado M; Schaich M
Haematologica; 2011 Jun; 96(6):e31. PubMed ID: 21632839
[No Abstract] [Full Text] [Related]
28. Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis.
Hasan SK; Mays AN; Ottone T; Ledda A; La Nasa G; Cattaneo C; Borlenghi E; Melillo L; Montefusco E; Cervera J; Stephen C; Satchi G; Lennard A; Libura M; Byl JA; Osheroff N; Amadori S; Felix CA; Voso MT; Sperr WR; Esteve J; Sanz MA; Grimwade D; Lo-Coco F
Blood; 2008 Oct; 112(8):3383-90. PubMed ID: 18650449
[TBL] [Abstract][Full Text] [Related]
29. Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis.
Vicari AM; Ciceri F; Folli F; Lanzi R; Colombo B; Comi G; Camba L
Leukemia; 1998 Mar; 12(3):441-2. PubMed ID: 9529141
[No Abstract] [Full Text] [Related]
30. Acute myelogenous leukemia following mitoxantrone treatment for multiple sclerosis.
Mogenet I; Simiand-Erdociain E; Canonge JM; Pris J
Ann Pharmacother; 2003 May; 37(5):747-8. PubMed ID: 12708958
[No Abstract] [Full Text] [Related]
31. Mitoxantrone-associated acute myelogenous leukemia in a patient with high-risk adenocarcinoma of the prostate: a case report and brief review.
Bowles DW; Flaig TW
Cancer Invest; 2006; 24(5):517-20. PubMed ID: 16939961
[TBL] [Abstract][Full Text] [Related]
32. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
Lebrun C; Debouverie M; Vermersch P; Clavelou P; Rumbach L; de Seze J; Wiertlevski S; Defer G; Gout O; Berthier F; Danzon A
Mult Scler; 2008 Apr; 14(3):399-405. PubMed ID: 18420778
[TBL] [Abstract][Full Text] [Related]
33. [Acute leukaemia in two multiple sclerosis patients treated with mitoxantrone].
Nollet S; Berger E; Deconinck E; Baldauf E; Rumbach L
Rev Neurol (Paris); 2006 Feb; 162(2):195-9. PubMed ID: 16518259
[TBL] [Abstract][Full Text] [Related]
34. [Immunosuppressive therapy of multiple sclerosis with mitoxantrone].
Mauch E; Kornhuber HH
Fortschr Neurol Psychiatr; 1993 Dec; 61(12):410-7. PubMed ID: 8112704
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of pediatric patients treated with mitoxantrone for multiple sclerosis.
Kornek B; Bernert G; Rostasy K; Mlczoch E; Feucht M; Prayer D; Vass K; Seidl R
Neuropediatrics; 2011 Feb; 42(1):7-12. PubMed ID: 21557144
[TBL] [Abstract][Full Text] [Related]
36. Secondary chronic myelomonocytic leukemia with monosomy 7 after successful treatment of acute promyelocytic leukemia.
Jeddi R; Gouider E; Benneji H; Mnif S; Ben Abid H; Belhadjali Z; Meddeb B
Pathol Biol (Paris); 2008 May; 56(3):162-3. PubMed ID: 18178033
[TBL] [Abstract][Full Text] [Related]
37. Complex translocations derived stepwise from standard t(15;17) in a patient with variant acute promyelocytic leukemia.
Miyazaki K; Kikukawa M; Kiuchi A; Shin K; Iwamoto T; Ohyashiki K
Cancer Genet Cytogenet; 2007 Jul; 176(2):127-30. PubMed ID: 17656255
[TBL] [Abstract][Full Text] [Related]
38. Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone.
Heesen C; Bruegmann M; Gbdamosi J; Koch E; Mönch A; Buhmann C
Mult Scler; 2003 Mar; 9(2):213-4. PubMed ID: 12708818
[No Abstract] [Full Text] [Related]
39. The first case of mitoxantrone exposure in early pregnancy.
De Santis M; Straface G; Cavaliere AF; Rosati P; Batocchi AP; Caruso A
Neurotoxicology; 2007 May; 28(3):696-7. PubMed ID: 17227680
[TBL] [Abstract][Full Text] [Related]
40. [Use of mitoxantrone in early multiple sclerosis with malignant disease course. Observational study in 30 patients with clinical and MRI outcomes after one year].
Ory S; Debouverie M; Le Page E; Pelletier J; Malikova I; Gout O; Roullet E; Vermersch P; Edan G
Rev Neurol (Paris); 2008 Dec; 164(12):1028-34. PubMed ID: 18808781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
